Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1997-12-12
2000-01-11
Krass, Frederick
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514212, 5142222, 5142278, 5142282, 5142288, 5142305, 514241, 514252, 514278, 514361, 514362, 514363, 514364, 514365, 514374, 514381, 514382, 514393, 514394, 514397, 514406, 514409, A61K 31435, A61K 3154, A61K 3140, A61K 31425
Patent
active
060136448
ABSTRACT:
The present invention is directed spiro-substituted azacycles of formula I: (wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, k, l and m are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-1, CCR-2, CCR-2A, CCR-2B, CCR-3, CCR-4, CCR-5, CXCR-3, and/or CXCR-4.
Maccoss Malcolm
Mills Sander G.
Springer Martin S.
Krass Frederick
Merck & Co. , Inc.
Rose David L.
Thies J. Eric
LandOfFree
Spiro-substituted azacycles as modulators of chemokine receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiro-substituted azacycles as modulators of chemokine receptor , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiro-substituted azacycles as modulators of chemokine receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1462501